Church & Dwight Acquires Matrixx Initiatives (Zicam) from Gryphon Investors

December 1, 2020

Church & Dwight Co., Inc. acquired Matrixx Initiatives, the maker of the Zicam over-the-counter cold remedy brand, from Gryphon Investors. The transaction, completed in December 2020, expands Church & Dwight’s consumer health portfolio and brings the Zicam brand and related product lines into its CPG portfolio (deal value reported at $530 million).

Buyers
Church & Dwight Co., Inc.
Targets
Matrixx Initiatives, Inc.
Sellers
Gryphon Investors
Location
New Jersey, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.